As the CAR-T field continues to explode with new companies, investment, and clinical collaborations, it’s more important than ever to stay ahead of the curve. Stakeholders across oncology are now turning to next generation developments and innovations to create the therapies of tomorrow.
Join you CAR-TCR community and network with 300+ innovators from large pharma, biotech, academia and regulatory boards at the only meeting dedicated to accelerating novel, new generation cell therapies that are safer, more effective and have meaningful impact in diseases beyond oncology.
You’ll hear insights into novel in-vivo delivery, innovations in gene, base & prime editing, novel discovery platforms, overcoming the hostile tumour microenvironment, improving persistence & durability for greater clinical outcomes, and more!
Key insights will be shared from Matterhorn Biosciences, Affini-T Therapeutics, Kiromic BioPharma, Antion Biosciences, Zelluna Immunotherapy, T-Kinfe Therapeutics, AffyImmune and many more. Leverage their knowledge to deliver value to your entire cell therapy team.
With 3 in-depth streams exploring the hottest Novel Platforms, Advanced Clinical Development of 3rd, 4th and 5th generation cell therapies, and the latest Manufacturing Innovations to revolutionise the production of large-scale cell therapy, this is the ONLY meeting bringing you the next generation developments and innovations needed to create the therapies of tomorrow.
Whether you are developing novel constructs, new clinical trial strategies or innovative manufacturing approaches for large scale production, this multi-tracked meeting can support your whole team and provide the tools needed to advance your own pipeline towards clinical and commercial success.
View official event guide now for the full meeting details!